Drugs for tuberculosis.
D000636:Aminosalicylic Acids / Q000009:adverse effects / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D003523:Cycloserine / Q000009:adverse effects / Q000627:therapeutic use; D004357:Drug Synergism; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D005000:Ethionamide / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use; D007612:Kanamycin / Q000009:adverse effects / Q000627:therapeutic use; D011718:Pyrazinamide / Q000009:adverse effects / Q000627:therapeutic use; D013307:Streptomycin / Q000009:adverse effects / Q000627:therapeutic use; D013828:Thioacetazone / Q000008:administration & dosage / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*; D014756:Viomycin / Q000009:adverse effects / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D011718:Pyrazinamide; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin